DNAmicBioSystems

Pioneering the first human protein-based cell-targeted delivery system

MISSION

The molecular bases of the vast majority of diseases are known, but they remain incurable because modern medicine lacks the ability to reach damaged cells and reprogram them. Our mission is to change that.

Utilizing human proteins and natural cellular communication, we offer a safer, precise, and more effective approach to cell engineering within the body.

We are setting a new standard in cellular therapy and regenerative medicine.

SCIENCE

Modular
Cellular Engineering
Platform

IN-VIVO • CELL-TARGETED • HUMAN PROTEIN-BASED

At DNAmic, we recognize the fundamental barriers that have long hindered progress in the development of next-generation molecular medicines. From the toxicity, inefficiency, and risks associated with viral vectors to the limited targeting capabilities and reduced effectiveness of non-viral systems, these challenges have constrained the potential of advanced medicine.
Our human-based engineering platform represents a pivotal leap in in-vivo cell engineering and reprogramming, designed to transcend these limitations.

JOIN US

Balancing ambition with openness

We specialize in cutting-edge cellular engineering and regenerative medicine, driven by a relentless pursuit of innovation. We are always eager to collaborate, exchange knowledge, and grow alongside fellow pioneers shaping the future of genetic and cellular therapies.

“ To everyone working on the next generation of genetic and cellular therapies, we offer a solution that removes the delivery challenge and accelerates the path to clinical impact.
The possibilities are vast, and the time to bring in vivo cellular engineering to its full potential is now.
Let’s build the future of medicine together. ”

Alfonso Fiz

CEO and CO-Founder DNAmic